… The β2-adrenergic receptor (β2AR), a prototype of the G protein-coupled receptor (GPCR) …
rapid bronchodilation and is therefore the current gold standard for therapeutic treatment of …

… to the future with both caution and hope, the potential metamorphosis of beta3adrenoceptor
agonists … e aim of this Commentary is to briefly review the current state of knowledge on beta-…

… fingerprint of the β 2 -adrenergic receptor (β 2 AR). β-adrenoceptors belong to rhodopsin-like …
& Matera, MG beta(2) -adrenoceptor agonists: current and future direction. British journal of …

Despite the availability of effective asthma treatments, some patients are poorly controlled
because of overreliance on short-acting β 2 -agonists (SABAs) and underuse of inhaled …

… The present review will address the most … is also present in other tissues and if further amino
acid decarboxylases are also involved in this process need to be further tested in the future. …

… high selectivity as a β 2 -adrenoceptor agonist, formoterol is … In the present investigation, the
immunomodulatory and … in both the forehand and backhand direction at 7 and 13 days post-…

… the complexity of the structure, function, and activity of cannabinoid receptors. In this
paper, we present the latest advances in research on the CB1R, its allosteric modulation and …

… -containing pharmacophore responsible for β 2 -adrenoceptor agonism in several LABAs has
been … In the present study, we compared the pharmacology of GS-5759 with representative …

… the aqueous path shared by other β2-AR agents. We observed a novel secondary path for
… action of long-acting β2-adrenergic receptor (β2-AR) agonists such as salmeterol has been …

In asthma, the clinical efficacy of inhaled corticosteroids (ICSs) is enhanced by long-acting β
2 -adrenoceptor agonists (LABAs). ICSs, or more accurately, glucocorticoids, promote …